90 related articles for article (PubMed ID: 22165287)
1. Methylation of adrenergic β1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol.
Jiang Q; Yuan H; Xing X; Liu J; Huang Z; Du X
Indian J Biochem Biophys; 2011 Oct; 48(5):301-7. PubMed ID: 22165287
[TBL] [Abstract][Full Text] [Related]
2. The expression level of myocardial β1-adrenergic receptor affects metoprolol antihypertensive effects: a novel mechanism for interindividual difference.
Liu H; Xing X; Huang L; Huang Z; Yuan H
Med Hypotheses; 2013 Jul; 81(1):71-2. PubMed ID: 23639286
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of the β1 adrenergic receptor in the myocardium results in insensitivity to metoprolol and reduces blood pressure in spontaneously hypertensive rats.
Huang Y; Liu XL; Wen J; Huang LH; Lu Y; Miao RJ; Liu X; Li Y; Xing XW; Yuan H
Mol Med Rep; 2017 Feb; 15(2):703-711. PubMed ID: 28000860
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by metoprolol of the antihypertensive effect of aspirin in young rats.
Tuttle RS; Banziger V; Patel S; Northrup N
J Pharmacol Exp Ther; 1985 Jul; 234(1):166-71. PubMed ID: 2989503
[TBL] [Abstract][Full Text] [Related]
5. The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk.
Chen L; Xiao T; Chen L; Xie S; Deng M; Wu D
Am J Med Sci; 2018 Mar; 355(3):235-239. PubMed ID: 29549925
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.
Suonsyrjä T; Donner K; Hannila-Handelberg T; Fodstad H; Kontula K; Hiltunen TP
Pharmacogenet Genomics; 2010 May; 20(5):342-5. PubMed ID: 20300048
[TBL] [Abstract][Full Text] [Related]
7. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
[TBL] [Abstract][Full Text] [Related]
8. Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia.
Arnold AS; Tang YL; Qian K; Shen L; Valencia V; Phillips MI; Zhang YC
J Hypertens; 2007 Jan; 25(1):197-205. PubMed ID: 17143192
[TBL] [Abstract][Full Text] [Related]
9. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
10. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
11. [Effect of chronic myocardial infarction on the distribution of beta-adrenoceptors in heart: experiment with dogs].
Li JJ; Qu XF; Li KS; Yu Y; Xi Y; Yue L; Wang GZ; Huang YL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2724-6. PubMed ID: 18167255
[TBL] [Abstract][Full Text] [Related]
12. Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.
Wu D; Li G; Deng M; Song W; Huang X; Guo X; Wu Z; Wu S; Xu J
J Int Med Res; 2015 Jun; 43(3):424-34. PubMed ID: 25823457
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats.
Di Verniero CA; Silberman EA; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Cardiovasc Pharmacol; 2008 Jun; 51(6):532-41. PubMed ID: 18475202
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation might be the epigenetic molecular mechanism of different antihypertensive efficacy of metoprolol in beta1-AR gene-directed therapy.
Jiang Q; Yuan H; Huang Z
Med Hypotheses; 2009 Mar; 72(3):364-5. PubMed ID: 19028419
[No Abstract] [Full Text] [Related]
15. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
[TBL] [Abstract][Full Text] [Related]
17. ADRB1 as a potential target for gene therapy of pregnancy induced hypertension and gestational diabetes mellitus.
Wieclawek A; Slawska H; Mazurek U
Clin Exp Hypertens; 2011; 33(6):422-6. PubMed ID: 21806475
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
Mahesh Kumar KN; Ramu P; Rajan S; Shewade DG; Balachander J; Adithan C
J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
Yu XC; Wang HX; Zhang WM; Wong TM
J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
[TBL] [Abstract][Full Text] [Related]
20. Changes in the in vitro pharmacodynamic properties of metoprolol in atria isolated from spontaneously hypertensive rats.
Di Verniero C; Höcht C; Opezzo JA; Taira CA
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):161-5. PubMed ID: 17250633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
